H. Woo, “Pharmacological Targeting of the NLRP3 trLRR Domain with Isothiazolinones Overcomes CRID3-Resistant Inflammation”, LangTaoSha Preprint Server. Jan. 30, 2026. doi: 10.65215/LTSpreprints.2026.01.30.000113.